Nikolay Vassilev

Prof. Nikolay Vassilev

Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
VAViolina T. Angelova
Violina T. Angelova
VVVioleta Valcheva
Violeta Valcheva
NVNikolay Vassilev
Nikolay Vassilev
RBRosen Buyukliev
Rosen Buyukliev
GMGeorgi Momekov
Georgi Momekov
BSBoris Shivachev
Boris Shivachev

1 December 2010 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AMAnelia Mavrova
Anelia Mavrova
DVDimitar Vuchev
Dimitar Vuchev
KAKameliya Anichina
Kameliya Anichina
NVNikolay Vassilev
Nikolay Vassilev

22 August 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
VAViolina T. Angelova
Violina T. Angelova
BGBorislav Ivanov Georgiev
Borislav Ivanov Georgiev
Tania PenchevaTania Pencheva
Tania Pencheva
IPIlza Pajeva
Ilza Pajeva
MRMiroslav Rangelov
Miroslav Rangelov
VTVirginia Tzankova
Virginia Tzankova
Alzheimer’s disease (AD) is considered a complex neurodegenerative condition which warrants the development of multitargeted drugs to tackle the key pathogenetic mechanisms of the disease. In this study, two novel series of melatonin- and donepezil-based hybrid molecules with hydrazone (3a–r) or sulfonyl hydrazone (5a–l) fragments were designed, synthesized, and evaluated as multifunctional ligands against AD-related neurodegenerative mechanisms. Two lead compounds (3c and 3d) exhibited a well-balanced multifunctional profile, demonstrating intriguing acetylcholinesterase (AChE) inhibition, promising antioxidant activity assessed by DPPH, ABTS, and FRAP methods, as well as the inhibition of lipid peroxidation in the linoleic acid system. Compound 3n, possessing two indole scaffolds, showed the highest activity against butyrylcholinesterase (BChE) and a high selectivity index (SI = 47.34), as well as a pronounced protective effect in H2O2-induced oxidative stress in SH-SY5Y cells. Moreover, compounds 3c, 3d, and 3n showed low neurotoxicity against malignant neuroblastoma cell lines of human (SH-SY5Y) and murine (Neuro-2a) origin, as well as normal murine fibroblast cells (CCL-1) that indicate the in vitro biocompatibility of the experimental compounds. Furthermore, compounds 3c, 3d, and 3n were capable of penetrating the blood–brain barrier (BBB) in the experimental PAMPA-BBB study. The molecular docking showed that compound 3c could act as a ligand to both MT1 and MT2 receptors, as well as to AchE and BchE enzymes. Taken together, those results outline compounds 3c, 3d, and 3n as promising prototypes in the search of innovative compounds for the treatment of AD-associated neurodegeneration with oxidative stress. This study demonstrates that hydrazone derivatives with melatonin and donepezil are appropriate for further development of new AChE/BChE inhibitory agents.

1 May 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AMAnelia Mavrova
Anelia Mavrova
DWDiana Wesselinova
Diana Wesselinova
NVNikolay Vassilev
Nikolay Vassilev
JTJordan A. Tsenov
Jordan A. Tsenov

1 July 2017 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
VAViolina T. Angelova
Violina T. Angelova
VVVioleta Valcheva
Violeta Valcheva
TPTania Pencheva
Tania Pencheva
YVYulian Voynikov
Yulian Voynikov
NVNikolay Vassilev
Nikolay Vassilev
BSBoris Shivachev
Boris Shivachev

2 September 2020 in Metabolites
Verified
Journal Article
Open access
PDF file
NVNikolay Vassilev
Nikolay Vassilev
SSSvetlana Simova
Svetlana Simova
MDMiroslav Dangalov
Miroslav Dangalov
LVLyudmila Velkova
Lyudmila Velkova
VAVenceslav Atanasov
Venceslav Atanasov
PDPavlina Dolashka
Pavlina Dolashka
Metabolic profiling based on 1H nuclear magnetic resonance (NMR) spectroscopy was applied with the aim to investigate the functional role of the metabolites in lyophilized mucus from the garden snail Helix aspersa. Twenty metabolites were unambiguously identified by 1H, 1D TOCSY, 2D J-resolved, 2D COSY, and 2D HSQC NMR spectra with water suppression. The metabolic profiles of two fractions with low molecular weight (Mw < 1 kDa and Mw < 3 kDa) are very similar. Metabolites with known antioxidant, antibacterial, and antimicrobial activity were detected by NMR metabolic analysis of mucus samples from Helix aspersa. Some of them were confirmed by mass spectrometric analysis. The primary structure of several peptides was identified in low molecular weight fractions (Mw < 1 kDa) by tandem mass spectrometry.